These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1613535)

  • 1. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schönmayr R; Schachenmayr W
    J Neurooncol; 1992 May; 13(1):1-11. PubMed ID: 1613535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA; Milroy R; Kaye SB
    Cancer Res; 1989 Aug; 49(16):4435-40. PubMed ID: 2743332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schachenmayr W; Schönmayr R
    J Neurooncol; 1992 May; 13(1):13-24. PubMed ID: 1613536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncolorimetric measurement of cell activity in three-dimensional histoculture using the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide: the pixel image analysis of formazan crystals.
    Colangelo D; Guo HY; Connors KM; Silvestro L; Hoffman RM
    Anal Biochem; 1992 Aug; 205(1):8-13. PubMed ID: 1443562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemosensitivity testing of primary human renal cell carcinoma by a tetrazolium based microculture assay (MTT).
    Mickisch G; Fajta S; Keilhauer G; Schlick E; Tschada R; Alken P
    Urol Res; 1990; 18(2):131-6. PubMed ID: 1692648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.
    Cole SP
    Cancer Chemother Pharmacol; 1986; 17(3):259-63. PubMed ID: 3742711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
    Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.
    Romijn JC; Verkoelen CF; Schroeder FH
    Prostate; 1988; 12(1):99-110. PubMed ID: 3126493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
    Sobottka SB; Berger MR
    Cancer Chemother Pharmacol; 1992; 30(5):385-93. PubMed ID: 1505077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
    Kirkpatrick DL; Duke M; Goh TS
    Leuk Res; 1990; 14(5):459-66. PubMed ID: 2345469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
    Kawada K; Yonei T; Ueoka H; Kiura K; Tabata M; Takigawa N; Harada M; Tanimoto M
    Acta Med Okayama; 2002 Jun; 56(3):129-34. PubMed ID: 12108583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of MTT-hybrid assay using human bone and soft tissue tumor cells].
    Kawai A; Ito S; Ozaki T; Inoue H; Tanabe G; Sato J
    Hum Cell; 1989 Sep; 2(3):283-9. PubMed ID: 2519217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.
    Jordan JP; Hand CM; Markowitz RS; Black P
    J Neurooncol; 1992 Sep; 14(1):19-35. PubMed ID: 1335043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
    Vistica DT; Skehan P; Scudiero D; Monks A; Pittman A; Boyd MR
    Cancer Res; 1991 May; 51(10):2515-20. PubMed ID: 2021931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity antitumor drug sensitivity testing.
    Kondo T; Wada K; Kawashima M; Sato Y; Yamauchi M
    Oncology; 1994; 51(6):535-9. PubMed ID: 7970499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrazolium [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] reduction by mycoplasmas.
    Kirchhoff H; Maass C; Runge M; Franz B; Schmidt R; Quentmeier H; Mühlradt PF
    Int J Syst Bacteriol; 1992 Jul; 42(3):506-8. PubMed ID: 1503978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
    Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
    J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.
    Ford CH; Richardson VJ; Tsaltas G
    Cancer Chemother Pharmacol; 1989; 24(5):295-301. PubMed ID: 2788039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current methodology of MTT assay in bacteria - A review.
    Grela E; Kozłowska J; Grabowiecka A
    Acta Histochem; 2018 May; 120(4):303-311. PubMed ID: 29606555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay.
    Shimoyama Y; Kubota T; Watanabe M; Ishibiki K; Abe O
    J Surg Oncol; 1989 May; 41(1):12-8. PubMed ID: 2716329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.